Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating costs and expenses:        
Research and development $ (487,519) $ (927,069) $ (951,301) $ (1,633,340)
General and administrative (890,779) (1,066,517) (1,754,152) (2,188,589)
Loss from operations (1,378,298) (1,993,586) (2,705,453) (3,821,929)
Other income (expense):        
Other income (expense) 735 (32,529) 490 (27,131)
Interest income (expense) 163 (61) 313 366
Total other income (expense) 898 (32,590) 803 (26,765)
Net loss (1,377,400) (2,026,176) (2,704,650) (3,848,694)
Deemed dividend     (3,879,447)  
Net loss applicable to common stockholders $ (1,377,400) $ (2,026,176) $ (6,584,097) $ (3,848,694)
Basic and diluted loss per share $ (1.56) $ (2.78) $ (7.79) $ (5.29)
Weighted-average shares of common stock outstanding, basic and diluted 882,107 728,929 844,749 727,697